NANYANG BIOLOGICS PTE. LTD.

Company Profile

Nanyang Biologics (NYB) is a biotechnology company leveraging AI to revolutionize drug discovery and develop innovative therapeutics inspired by nature. Our AI-powered drug discovery platform, DTIGN, is developed by scientists with real-world drug discovery experience. It is revolutionizing drug discovery with advanced AI, including a state-of-the-art bioactivity prediction engine designed to enhance the identification of hit molecules and accelerate clinical success. Our assessment shows that DTIGN improves bioactivity prediction accuracy by 27.03%, achieves a 64× higher hit rate efficiency, and cuts bioactive compound discovery timelines by 68.2% compared to other AI models. These breakthroughs have earned DTIGN’s recognition in the prestigious IEEE Journal. Beyond pharmaceuticals, NYB enables the identification, repurposing, and optimization of active ingredients from natural sources, helping to develop functional foods, dietary supplements, beauty and personal care products.

• AgriTech & FoodTech
• Artificial Intelligence
• Data Centres
• HealthTech
• AI & Nutrition
• Biotechnology
• Machine Learning
• Training
• Artificial Intelligence
• Data Storage Solutions
• eHealth, Telemedicine, Telematics, Telemetry
• Healthcare Information Systems, Software (HIS)
• Research & Development